Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma

Advanced Lung Squamous Carcinoma Clinical Trial

Official title: Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma Based on Chemotherapy for Advanced Non-small Cell Lung Squamous Carcinoma Patients：a Randomized Controlled,Open, Multicenter Clinical Study

Status Recruiting

Clinical Trial Summary

Explore the efficacy and safety of the treatment of Endostar continuous intravenous injection pump combined DP scheme for first-line advanced lung squamous carcinoma and maintenance treatment., and explore the predicted biomarkers.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Advanced Lung Squamous Carcinoma
• Carcinoma
• Carcinoma, Squamous Cell

• NCT number: NCT02513342
• Study type: Interventional
• Source: Nanjing NingQi Medicine Science and Technology Co., Ltd.
• Contact: Yin Qingfeng, manager
• Phone: 0086-02585632992
• Email: y_qingfeng@163.com
• Status: Recruiting
• Phase: Phase 4
• Start date: March 2015
• Completion date: April 2018